AtriCure, Inc.: FDA filings under this applicant name
FDA lists 60 510(k) clearances under the applicant name “AtriCure, Inc.” (first 2001, latest 2026), plus 2 PMA decisions, across 9 product codes in 3 review panels. Median 510(k) review time under this name: 35 days. Since 2017 the median was 29 days, against 97 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 3 | 30 |
| 2013 | 2 | 30 |
| 2014 | 4 | 40 |
| 2015 | 1 | 63 |
| 2016 | 3 | 51 |
| 2017 | 4 | 29 |
| 2018 | 6 | 29 |
| 2019 | 5 | 85 |
| 2020 | 1 | 281 |
| 2021 | 3 | 29 |
| 2022 | 1 | 233 |
| 2023 | 2 | 28 |
| 2024 | 4 | 137 |
| 2025 | 3 | 30 |
| 2026 | 1 | 30 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name AtriCure, Inc. took a median 29 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 97 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| OCL | Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue | 20 | 20 |
| FZP | Clip, Implantable | 11 | 11 |
| GEH | Unit, Cryosurgical, Accessories | 8 | 8 |
| GXH | Device, Surgical, Cryogenic | 7 | 7 |
| PZX | Left Atrial Appendage Clip, Implantable | 7 | 7 |
| GEI | Electrosurgical, Cutting & Coagulation & Accessories | 4 | 4 |
| FTD | Lamp, Surgical | 2 | 2 |
| OCM | Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation | 2 | 0 |
| DYB | Introducer, Catheter | 1 | 1 |
Review panels
- Cardiovascular (30)
- General and Plastic Surgery (25)
- Neurology (7)
Most recent AtriCure, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K263319 | ACHM30 AtriClip FLEX-Mini LAA Exclusion System | PZX | 2026-10-21 | 30 |
| K252056 | Isolator® Synergy EnCompass Clamp and Guide system (OLH, OSH, GPM100) | OCL | 2025-07-24 | 23 |
| K250371 | cryoICE cryoXT cryoablation probe (cryoXT) | GXH | 2025-04-10 | 59 |
| K243860 | AtriClip PRO-Mini LAA Exclusion System (PROM) | PZX | 2025-01-15 | 30 |
| K243157 | AtriCure cryoICE BOX (ACM) | GXH | 2024-10-29 | 29 |
| K234151 | Isolator Synergy EnCapture Ablation System (EMH) | OCL | 2024-08-27 | 242 |
| K234125 | AtriClip FLEX-Mini LAA Exclusion System (ACHM) | PZX | 2024-07-29 | 214 |
| K233959 | EPi-Ease Epicardial Access Device (EAS) | DYB | 2024-02-13 | 60 |
| K233407 | AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (ACH1); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (ACH2); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (PRO1); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (PRO2); AtriClip PRO-V LAA Exclusion System (PROV); AtriClip Flex-V LAA Exclusion System with preloaded V Clip (ACHV) | PZX | 2023-11-02 | 28 |
| K233170 | cryoICE cryoSPHERE+ Cryoablation Probe (CRYOSP); cryoICE cryoSPHERE+ Cryoablation Probe (CRYOSP-L); cryoICE cryoSPHERE MAX Cryoablation Probe (CRYOSMAX); cryoICE cryoSPHERE MAX Cryoablation Probe (CRYOSMAX-L) | GXH | 2023-10-26 | 29 |
50 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P200002 | PMA | EPi-Sense Guided Coagulation System | 2021-04-28 |
| P100046 | PMA | ATRICURE SYNERGY ABLATION SYSTEM | 2011-12-14 |
Recalls
13 product recalls in 9 recall events; 2 initiated in the last five years. Most recent: 2023-11-28.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named AtriCure, Inc. is the lead sponsor of 32 device studies on ClinicalTrials.gov (9 active or recruiting). Most recent:
- NCT06989775: BoxX-NoAF Clinical Trial (Recruiting, started 2025-10-24)
- NCT06908538: Cryo NerVe Block Extremity AmputatioN RegIStry for Post Operative and pHantom Limb Pain (Recruiting, started 2025-04-01)
- NCT05111015: Tracking Results of Ablations to Combat AF Registry Generation 2 (Recruiting, started 2024-03-11)
- NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial (Active not recruiting, started 2023-01-25)
- NCT05280093: HEAL-IST IDE Trial (Active not recruiting, started 2022-05-31)
SEC filings
AtriCure, Inc. (ATRC): EDGAR filings, CIK 1323885. An SEC registrant with the same name, matched by name only.
Frequently asked questions
How many FDA 510(k) clearances are listed under AtriCure, Inc.?
FDA lists 60 510(k) clearances under the applicant name “AtriCure, Inc.” (first 2001, latest 2026), plus 2 PMA decisions, across 9 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by AtriCure, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name AtriCure, Inc. is 35 days. Since 2017: 29 days, versus 97 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under AtriCure, Inc.?
The most frequent FDA product codes under this applicant name are OCL (Surgical Device, For Cutting, Coagulation, And/Or Ablation Of Tissue, Including Cardiac Tissue, 20); FZP (Clip, Implantable, 11); GEH (Unit, Cryosurgical, Accessories, 8).
Next steps
- See all 60 AtriCure, Inc. clearances with predicates and recalls
- Run predicate analysis for product code OCL, AtriCure, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.